The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer.
暂无分享,去创建一个
[1] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[2] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .
[3] D. Comings. A general theory of carcinogenesis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Knudson,et al. [Heredity and cancer in man]. , 1953, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.